Merkliste 
 1 Ergebnisse 
 
1

Risankizumab shows faster response in bio naïve than in bio..:

Mastorino, L. ; Castelli, F. ; Stroppiana, E....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  10 - p. , 2022